1. Introduction {#s0005}
===============

Across the psychosis spectrum, from youth exhibiting risk syndromes to patients with schizophrenia, there is evidence for basal ganglia abnormalities, including functional and structural differences, as well as dopaminergic receptor differences ([@bb0135], [@bb0155], [@bb0205], [@bb0210], [@bb0435], [@bb0480], [@bb0605]). Leading etiological theories of psychosis have implicated the basal ganglia and fronto-striatal dysfunction ([@bb0175], [@bb0470]). Indeed, the third and most recent version of the dopamine hypothesis purports that numerous factors including genetic, environmental, and psychosocial factors, converge to result in dopaminergic dysfunction, and a final common pathway rests at the level of presynaptic striatal dopaminergic control ([@bb0215]). Given that the basal ganglia and their function are highly reliant upon a healthy dopaminergic system, as evidenced by diseases such as Parkinson\'s and Huntington\'s (e.g., [@bb0050], [@bb0105], [@bb0405]), and the purported role of dopamine in psychosis and schizophrenia, these brain areas are of particular interest as we try to better understand the heterogeneous signs and symptoms experienced by patients with schizophrenia.

Connections between the basal ganglia and cortex are subserved by parallel circuits connecting distinct cortical regions with distinct regions of the basal ganglia. There are four primary cortico-striatal-pallido-thalamic circuits---the motor, occulomotor, limbic, and prefrontal circuits---defined based on their cortical projections ([@bb0005], [@bb0010], [@bb0195], [@bb0340], [@bb0345], [@bb0350]). Based on the respective cortical projections, each regulates distinct behaviors and functions including motor behavior, reward processing, emotion, and higher-order cognitive processes such as language, working memory, and executive function ([@bb0555]). These circuits are organized in direct and indirect pathways linked by excitatory glutamatergic and inhibitory GABA-ergic projections. However, each passes through the basal ganglia, which are richly innervated with dopamine (DA), that balances the direct and indirect pathways through differential actions of DA on striatal D1 and D2 receptors ([@bb0110], [@bb0410], [@bb0400]). Thus DA receptor, or broader circuit abnormalities may affect those tasks regulated by basal ganglia structures, as well as a host of apparently disparate functions characterized in schizophrenia ([@bb0365], [@bb0470]). Indeed, in a recent review, [@bb0095] suggested that the circuit linking the dorsal striatum to the lateral prefrontal cortex may be especially important in the pathophysiology of psychosis, as dysfunction is seen across the spectrum of risk and disease.

While early work was conducted using animal models, the parallel loops of the basal ganglia have been demonstrated in the human brain as well using diffusion tensor imaging ([@bb0120]), resting state functional connectivity ([@bb0115]a), and with meta-analytic investigations of co-activation patterns ([@bb0445]). Indeed, the work of [@bb0120] demonstrated a connectivity gradient with the cortex that follows a rostral to caudal pattern across structures (caudate, putamen, pallidum). The connectivity profiles of the most rostral areas are associated with the orbital and medial prefrontal cortex and move caudally to the prefrontal, premotor, and motor cortices. The diffuse cortical connections, in conjunction with behavioral evidence in patient populations suggesting that dopaminergic and basal ganglia dysfunction result in motor, cognitive, and affective deficits ([@bb0250], [@bb0345], [@bb0350], [@bb0555]), indicate that the basal ganglia are crucial for performance across domains. Furthermore, this suggests that within each nucleus, processing occurs on a variety of task information, due to the differing input and output loops with the cerebral cortex.

The wide array of behavioral contributions of the basal ganglia and purported role of dopamine in psychosis make an improved understanding of basal ganglia function in schizophrenia of particular interest. As noted, structural differences in basal ganglia volume are seen across the psychosis spectrum. Smaller volume in basal ganglia nuclei is seen in generally healthy individuals who report psychotic-like experiences (non-clinical psychosis; [@bb0360]), individuals with schizotypal personality disorder ([@bb0300]), those at clinical high risk for psychosis (CHR; i.e., exhibiting prodromal syndromes; [@bb0365]), and finally, in those with a diagnosis of schizophrenia (e.g., [@bb0085]). In addition to these structural differences, functional connectivity patterns of the basal ganglia are also altered in CHR individuals ([@bb0090]), as well as in patients with schizophrenia ([@bb0255], [@bb0480], [@bb0560]). These findings suggest a general decrease in resting state connectivity of the basal ganglia in key cortical networks, though there is some evidence for increases in at-risk individuals, and when basal ganglia connectivity is investigated in conjunction with the default mode network ([@bb0090], [@bb0480]). However, there has also been an increase in the number of investigations completing task-based functional imaging (fMRI) in schizophrenia, that stand to provide further insight into the basal ganglia and basal ganglia function in this important patient population. Synthesizing across these studies to look at basal ganglia activation patterns stands to provide critical new insights into our understanding of the basal ganglia in schizophrenia.

Here, we conducted an activation likelihood estimation (ALE) meta-analysis, which produces an estimation of the likelihood that a given voxel, when considering all the voxels in the brain, is activated during the performance of a particular task ([@bb0130]). We focused on specific tasks that align with basal ganglia circuits to address two key questions. First, what is the functional topography of task-based activation in the basal ganglia in healthy adults? While both diffusion tensor and resting state imaging have provided us with an excellent understanding of basal ganglia networks in the human brain ([@bb0115]b; [@bb0120]), and though there is a vast fMRI literature, to our knowledge the functional topography of the basal ganglia has not been mapped in healthy adults with meta-analytic methods. Furthermore, understanding basal ganglia organization in healthy controls is important for work in schizophrenia. Though our methodologies are optimized for investigating patients with schizophrenia, our analyses of the control participants allow for important new insights as to the functional topography of the basal ganglia based on activation patterns across task domains. With respect to the functional topography in healthy controls, we expected to see a gradient of activation foci across studies in patterns consistent with the rostral to caudal connectivity gradient demonstrated by [@bb0120] within individual basal ganglia nuclei. As such, we expected to see some degree of motor and cognitive activation across all the nuclei in the basal ganglia, but in an organized manner. The most rostral regions of the caudate and putamen would be associated with higher cognitive processing, while the most caudal would be associated with motor tasks. With respect to reward, we also expected to see significant activation overlap in the ventral striatum. Second, we sought to understand differences in basal ganglia activation and functional topography in individuals with schizophrenia. How do these activation patterns differ across task domains in the presence of this disorder? While the dopamine hypothesis ([@bb0215]) and hyperkinetic movements seen in CHR and schizophrenia spectrum populations indicate an excess of dopamine in the basal ganglia in patients with schizophrenia ([@bb0205], [@bb0210], [@bb0370], [@bb0430]), functional connectivity of the basal ganglia seems to be decreased. Given these functional connectivity decreases we predicted that the patient group would show decreased activation across task domains when compared to controls. Furthermore, this would be consistent with our recent meta-analytic work investigating the cerebellum, where we also saw decreased activation across studies, relative to controls ([@bb0035]). However, we did not expect to see alterations in the topography of activation, and as such we expected that the predicted rostral-caudal gradient of activation foci would remain the same.

2. Method {#s0010}
=========

2.1. Literature search {#s0015}
----------------------

Articles for inclusion were identified using two independent PubMed literature searches (<http://www.ncbi.nlm.nih.gov/pubmed>). For both searches, we used identical sets of search limits which included "Adult 19--44", "English", and "Humans". Our meta-analysis was limited to this adult group so as to minimize the potential confounding effects of advanced age with disease state, as the basal ganglia are impacted by aging and there are age-related decreases in dopamine (reviewed in [@bb0505]). Additional exclusion criteria for studies were consistent with our previous functional neuroimaging meta-analyses ([@bb0035], [@bb0045]). That is, we excluded articles that did not use functional neuroimaging methods, did not report coordinates in standard space, studies using only region of interest analyses, and studies that did not use standard contrast analysis (e.g., independent components analysis). In addition, for the purposes of our investigation of the basal ganglia here, we limited our analyses to studies that reported activation in the basal ganglia, after completing two broad searches of the literature. However, it is notable that we included activations that were described as "midbrain" as this is the location of the substantia nigra, a component of the basal ganglia. With current imaging methods, specifically locating the substantia nigra can be particularly challenging, and as such we were more liberal in our inclusion of midbrain activation in hopes of encompassing this region. Also of note, the activation could be in either patients or controls. That is, studies were included even if activation was only limited to one group.

Search terms were defined so as to encompass the neuroimaging literature broadly, and to parallel the strategy used in our recent meta-analysis of the cerebellum in psychosis ([@bb0035]). All analyses and papers included were those available as of May 15, 2015. The search "schizophrenia AND neuroimaging" returned 2424 articles, while our second search of "basal gangl\* AND schizophrenia AND imaging" returned 258 papers. The first search was designed to broadly encompass all of the available neuroimaging literature on patients with schizophrenia. This allowed us to cast a wide net. Our second search was more focused on the basal ganglia in order to make sure that we included as many studies as possible showing basal ganglia activation in studies of schizophrenia (either in controls or patients). As described above, we limited our analyses only to those studies including activation in the basal ganglia in one group. First, this is critical for our ability to investigate group differences in basal ganglia activation across studies, as a meta-analysis of over 2500 manuscripts, of which only a subset included activation of interest, would actually limit our power to detect group differences. We are unable to detect differences if there is no activation present in the first place. Second, many of the studies that were the result of this search included tasks where one might not expect any activation in the basal ganglia. As such, we limited our inclusion sample, to only look at group differences in investigations where basal ganglia activation was present.

As indicated, because the basal ganglia are known to have multiple loops and connections with the cortex in prefrontal, motor, and limbic regions ([@bb0120]), we focused on task domains associated with these distinct loops that are also known to be impacted in patients with schizophrenia. Thus, we included functional studies where the task used fell into one of the following categories: motor function, executive function/attention, working memory, emotional processing, language, and reward processing ([@bb0080], [@bb0150], [@bb0295], [@bb0335], [@bb0410], [@bb0430], [@bb0530]). Notably however, because we were investigating a clinical population, the tasks were designed to optimize performance in both groups. As such, it may be the case that we are underestimating the activation in the healthy control groups due to task difficulty and other related factors. Furthermore, we did not take into account task performance as our primary interest was based on functional activation patterns, and this was not an exclusion criteria in our selection of papers for analysis.

Papers for inclusion were narrowed down by first excluding those that did not use functional imaging. Then, the remaining papers with functional analyses were investigated to determine whether or not they used standard general linear model analyses, and included activation foci in the basal ganglia presented in standard space (either Montreal Neurological Institute (MNI) or Talairach). Finally, all control data come from papers that included both controls and patients with schizophrenia, though in several instances papers that only investigated patients with schizophrenia were included. After thoroughly examining all papers returned in our PubMed searches to ensure that they met the inclusion criteria for our study, we ended up with 42 studies (concatenated across all domains) for inclusion in our analyses, and this resulted in data from a total of 707 patients with schizophrenia and 583 controls (concatenated across all 42 studies). The included articles as well as description of the tasks included and the neuroimaging contrasts investigated are presented in [Table 1](#t0005){ref-type="table"}.Table 1Study information for all papers included in the meta-analysis, including imaging modality, sample size, a general task description and the number of foci per group. Each general task domain is grouped separately.Table 1StudyImaging modalityN, SCZN, CONTask\# SCZ foci\# CON fociEmotion[@bb0285]3 T MRI3737Retrieval of high arousal emotional images relative to neutral images01[@bb0545]3 T MRI2121Preference (yes or no to the prompt "Like") in emotional faces (positive, negative, fear) contrasted with gender discrimination condition01[@bb0535]1.5 MRI1515Participants gave ratings of neutral, unpleasant, and pleasant IAPS pictures01[@bb0275]1.5 MRI560Emotional faces & participants indicated gender. Neutral relative to a control oval included here only at baseline assessment1n/a[@bb0550]PET1810Rating of emotional images (IAPS); contrasted emotional and non-aversive images02[@bb0440]1.5 T MRI105Implicit facial emotion processing during a gender discrimination task; Patient group included 5 paranoid and 5 non-paranoid individuals05[@bb0060]3 T MRI1421Retrieval of positive relative to neutral IAPS pictures02[@bb0235]1.5 T MRI1115Gender and emotion discrimination of emotional faces, relative to shapes02  Executive function/attention[@bb0610]3 T MRI2424Inhibitory control as measured using a stop-signal anticipation task. Included analyses of stop-signal probability parametric effects and successful and failed stop trials.918[@bb0305]1.5 T MRI2828Selective attention, auditory oddball; targets relative to baseline and novel stimuli04[@bb0475]1.5 T MRI1912Hayling sentence completion task with completion using the expected word, or an unrelated word (inhibition condition)02[@bb0070]1.5 T MRI1414Occulomotor delayed response task with saccades to peripheral locations01[@bb0565]3 T MRI1010Antisaccade task02[@bb0185]3 T MRI1614Multi-source interference task with three numbers with congruent and incongruent blocks01[@bb0420]PET1110Sustained attention, mental counting with auditory stimulation02  Language[@bb0325]3 T MRI1414Figurative language task made up of 96 pairs of words with literal or metaphoric associations, or no relationship. Processing across relation levels compared33[@bb0225]3 T MRI2424Word generation and word repetition013[@bb0455]3 T MRI1413Semantic word generation32[@bb0525]PET1812Word reading (nouns), relative to looking at nouns10[@bb0585]1.5 T MRI1211Listening to speech (English, Mandarin, and reversed English)20  Motor[@bb0200]3 T MRI2323Imitation, observation, and execution of finger and face movements78[@bb0390]1.5 T MRI33Self-paced finger tapping22[@bb0320]PET1211Implicit sequence learning (serial reaction time task) and random button presses03[@bb0395]1.5 T MRI1010Unilateral, finger-to-thumb opposition task (sequential movement); Patients divided into 3 groups of 10 based on medication. Here only the untreated group showed activation, so only 10 participants are represented12[@bb0280]1.5 T MRI66Implicit sequence learning02[@bb0330]1.5 T MRI88Sequential finger-to-thumb opposition and individually created random movement sequence. Analysis completed on only 7 subjects as one outlier per group was removed13  Reward[@bb0165]1.5 T MRI1517Instrumental reward learning task using fractal pictures and water reward (fluid withdrawal the night before) given on a probabilistic schedule24[@bb0220]1.5 T MRI220Reinforcement learning, with conditions for monetary gain, and avoiding monetary loss8n/a[@bb0485]3 T MRI2424Reversal learning task, two sessions of 100 trials with reward and punishment07[@bb0575]3 T MRI1616Monetary incentive task, parametric variation of wins43[@bb0170]1.5 T MRI1418Pavlovian reward learning task with water reward after fluid withdrawal, using fractal pictures02[@bb0385]3 T MRI2116Reward prediction error during Pavlovian cue-outcome card game with both expected and unexpected rewards012  Working memory[@bb0180]3 T MRI2522Verbal working memory, 2-back relative to 0-back. Data from controls in two groups of 11 and only include pre-TMS intervention02[@bb0310]2 T fMRI1617Verbal working memory Sternberg variant with incorrect lures03[@bb0475]1.5 T MRI1912N-back, 2-back relative to 0-back20[@bb0425]1.5 T MRI1211N-back (2-back)12[@bb0315]1.5 T MRI99Sternberg verbal working memory of digits at high (5) and low (2) memory load20[@bb0020]1.5 T MRI108Visual delayed match-to-sample task01[@bb0270]1.5 T MRI140N-back task, 2-back and 0-back in first-episode patients with genetic risk1n/a[@bb0260]PET1212N-back task (2-back) with shapes, relative to control focused attention task01[@bb0230]3 T MRI1818Sternberg verbal working memory task using letters, with medium and difficult load conditions04[@bb0600]1.5 T MRI1212N-back task (2-back) with neutral faces02

2.2. ALE meta-analysis {#s0020}
----------------------

All analyses were conducted using BrainMap GingerALE 2.3.5 (<http://brainmap.org>; [@bb0130], [@bb0125], [@bb0570]), using the most recent algorithm designed to minimize the impact of individual experiments ([@bb0570]). The foci were first concatenated together for analysis across all domains, and then were organized by specific task domain. In both cases, the foci were divided into those associated with patients and controls. Because there are two standard atlas spaces (MNI and Talairach) it is essential to ensure that all foci across studies are in the same space so as to more accurately compare the spatial locations of the activation foci. Thus, we converted all coordinates in Talairach space to MNI space. For all studies where the data were normalized directly to Talairach space, and for those that specified the use of the Lancaster transform (icbm2tal), we transformed them to MNI space using the Lancaster transform ([@bb0290]). We also used this approach for articles published after the Lancaster transform was made available, but for which there was no transform algorithm specified in the manuscript text. For articles where the Brett transform (mni2tal) was used to bring MNI data into Talairach space, and for those articles published prior to 2007 and there was no transform specified, we used the inverse Brett transform to bring the foci back to MNI space. All transformations were completed using tools available in GingerALE.

Activation foci in MNI space were organized into text files, which were then entered into GingerALE. The software algorithm computes ALE values for all voxels in the brain, and produces an estimation of the likelihood that a given voxel is activated during the performance of a particular task ([@bb0130]). As part of the analysis in GingerALE, a full-width half maximum (FWHM) Gaussian blur is used on each set of foci, though the size of the blur is adjusted automatically based on the number of subjects contributing to each respective set of foci ([@bb0130]). That is, the meta-analysis procedure takes into account the number of subjects in a particular study automatically. Thus, while the studies included here ranged greatly in the number of participants in both the patient and control groups, the analysis procedure itself accounted for this. In our analyses, the output indicated that the FWHM blur ranged from 8.7 to 12.97 mm, across all analyses. All analyses were conducted using the smaller more conservative mask option available in GingerALE. Within-group analyses for each task (and in the combined analysis pooling across all tasks) were evaluated using cluster-level correction, consistent with the recommendations of [@bb0125]. All ALE maps were first thresholded using an uncorrected p \< 0.001 as the cluster-forming threshold, and then with FDR p \< 0.05 for cluster-level inference, with 5000 threshold permutations. Group contrasts (subtraction analyses) and conjunctions for each individual task were evaluated using an uncorrected p \< 0.05 with 10,000 p-value permutations and a minimum cluster size of 50 mm^3^, while the pooled comparison had a minimum cluster size of 100 mm^3^. This approach was taken because GingerALE is not very robust when small numbers of studies (fewer than 15 per group) are used for group contrasts. However, this is consistent with the approach we took in our meta-analytic work investigating the cerebellum ([@bb0040]), and has also been used in other recent meta-analyses (e.g., [@bb0160], [@bb0520]). The cluster minima were implemented to account, at least in part, for the lack of additional statistical correction. While we are looking at small structures given our focus on the basal ganglia, we have chosen this more conservative cluster size in the interest of limiting false positives as effectively as possible. The resulting foci from all analyses were localized using the AAL atlas in MRICron, as well as the Harvard-Oxford subcortical atlas in FSL.

To investigate the functional topography of the basal ganglia in the control group only, we conducted contrast analyses comparing foci associated with a particular task domain (for example, "motor") and we compared these foci with the combined foci for all other task domains ("everything except motor"). This allowed us to investigate whether there are any foci of activation for a particular task domain, distinct from the activation for all of the other task domains in question, which is crucial for investigating topographical functional organization across studies.

Contrast analyses comparing patients with schizophrenia and controls were computed using the foci from each group, as opposed to using group contrasts that were in some cases reported in the original studies included here. They represent a subtraction of the resulting ALE maps (or addition in the case of the conjunction analysis). Not all studies included healthy controls in conjunction with patients with schizophrenia. Therefore, to increase our power and include all possible investigations, we contrasted the foci between the groups on all of the behavioral domains of interest and pooled across tasks.

3. Results {#s0025}
==========

3.1. Task activation overlap in controls {#s0030}
----------------------------------------

Overlap in activation across studies was first investigated for the control and patient groups separately. The control analysis was especially important for establishing normative patterns of activation and the functional topography of the basal ganglia in the healthy adult brain. While resting state and diffusion tensor parcellations have provided excellent maps of the circuitry of these regions ([@bb0120], [@bb0115]) that inform our interpretation of the functional data, the topography with respect to specific task domains, up to this point, had not been delineated to our knowledge. [Table 2](#t0010){ref-type="table"} presents detailed information about the peak coordinates, weighted centers, cluster sizes, and anatomical region of activation by group and task domain, while [Fig. 1](#f0005){ref-type="fig"} shows the patterns of overlapping activation in each task domain, separated by group. General patterns will be summarized here.Fig. 1ALE result maps for each task domain presented for the controls (**A**) and the patients with schizophrenia (**B**). Both coronal and axial slices are presented. Notably, in the patients with schizophrenia there were no significant areas of functional activation overlap for the emotion and executive function/attention domains, and as such no clusters are pictured.Fig. 1Table 2Significant clusters of overlap for each individual task domain separated by group. Results include the cluster size, the weighted center of the significant overlap, the local peaks within the cluster as well as the anatomical location within the basal ganglia of the activation overlap. Notably, there were no significant areas of activation overlap in the patient group for the emotion and executive function/attention task domains and as such no results are included.Table 2ClusterCluster size (mm^3^)Weighted center (x, y, z)Local Extrema (x, y, z)LocationALE value (× 10^− 3^)EmotionControlsCluster 1824− 13.1, 9.4, 13.8− 12, 10, 14Caudate (body)14.16Cluster 27527.2, 4.6, − 2.94, 4, − 4Caudate (head)10.60Cluster 324019.9, 24.5, − 3.420, 24, − 4Caudate (HEAD)7.26Cluster 4224− 21, − 18, 18− 21, − 18, 18Thalamus8.23Cluster 522418, − 18, 2118, − 18, 21Caudate (tail)8.23  PatientsN/A  Executive function/attentionControlsCluster 1328823.5, 6.7, 6.724, 16, 0Putamen13.4524, 0, 18Putamen12.0818, 8, 12Caudate (body)9.8824, 0, 4Putamen9.6928, − 4, 8Putamen9.6716, 8, 0Putamen9.22Cluster 2648− 7.5, 11, − 13.8− 8, 12, − 14Sub-lobar Gray Matter15.02Cluster 354411.8, 11.2, − 14.112, 12, − 14Sub-lobar Gray Matter13.04Cluster 4392− 12.9, 2.4, 6.8− 12, 0, 4Lentiform Nucleus Gray Matter9.55Cluster 5160− 23.9, − 7.9, 12.1− 24, − 8, 12Putamen9.02Cluster 615220.2, − 11.8, 8.120, − 12, 8Thalamus8.95Cluster 713612.2, 0.1, 4.112, 0, 4Thalamus8.86Cluster 880− 27.6, − 3.6, 4.4− 28, − 4, 4Putamen8.80  PatientsN/A  LanguageControlsCluster 11032− 16.5, 11.6, 3.7− 18, 10, 4Putamen12.44− 16, 20, − 2Caudate (head)9.00− 10, 10, 10Caudate (body)7.78Cluster 2352− 10.5, − 2.8, 17.7− 10, 0, 16Caudate (body)9.27− 12, − 8, 20Caudate (body)7.88Cluster 3152− 20.2, 9.6, − 7.4− 20, 10, − 8Putamen8.80Cluster 413628.3, − 14.1, − 7.928, − 14, − 8Lateral Globus Pallidus8.75Cluster 5136− 0.01, 12.2, 1.90, 12, 2Caudate (body)8.77Cluster 612822.2, 13.6, − 7.522, 14, − 8Putamen8.69Cluster 712810, 23.4, 4.610, 24, 4Caudate (body)8.64Cluster 8128− 20.2, − 43.8, 9.7− 20, − 44, 10Brodmann area 308.72Cluster 912020.3, 7.7, − 11.320, 8, − 12Putamen8.66Cluster 10120− 26.3, − 16.1, − 10.4− 26, − 16, − 10Lateral Globus Pallidus8.70Cluster 1112012.3, 13.3, 20.312, 14, 20Brodmann area 338.67Cluster 1280− 25.2, 1.8, 1.6− 26, 2, 2Putamen7.58  PatientsCluster 1760− 22.3, 0, 10.6− 22, 0, 10Putamen9.14Cluster 266422, 28, 422, 28, 4Caudate (body)7.96  MotorControlsCluster 12200− 21.6, 3.6, − 2.6− 20, 4, − 4Putamen19.48− 26, 2, 8Putamen9.37Cluster 2142423.6, 2.4, 7.222, − 2, 10Putamen13.5328, − 2, − 2Putamen9.69Cluster 3256− 29.7, − 11.7, − 1.9− 30, − 12, − 2Putamen9.29  PatientsCluster 1313622.8, − 1.5, 6.924, 2, 10Putamen16.49  RewardControlsCluster 1376015.1, 6, 3.614, 6, 10Caudate (body)21.7516, 6, − 2Lateral Globus Pallidus13.7130, 4, 0Putamen9.8030, 0, 2Putamen9.50Cluster 22440− 13.8, 6.8, − 0.08− 10, 8, 0Caudate (head)18.16− 24, 4, − 6Putamen13.91− 10, 2, 8Caudate (body)9.51− 6, 4, 16Caudate (body)8.74Cluster 321123.7, − 21.5, − 12.54, − 23, − 10Red Nucleus19.838, − 18, − 10Red Nucleus17.19− 2, − 24, − 18Red Nucleus14.47Cluster 464− 11, − 7, 3− 12, − 6, 2Thalamus8.00  PatientsCluster 11648− 13.9, 10.9, − 8.1− 12, 10, − 6Caudate (head)15.71Cluster 281612.9, 12, − 3.212, 12, − 2Caudate (head)8.9614, 12, − 12Sub-lobar Gray Matter8.8812, 12, 4Caudate (body)8.72Cluster 366425.6, 6, 926, 6, 8Putamen11.72Cluster 41609, 24, 610, 24, 6Caudate (body)8.41Cluster 516015, 3, 1814, 4, 18Caudate (body)8.07Cluster 616015, 0, 2715, 0, 27Brodmann area 248.06  Working memoryControlsCluster 12344− 17.6, − 0.2, 11.6− 18, 0, 10Putamen30.11Cluster 21112− 20.3, 10.1, − 8− 22, 10, − 10Putamen13.47− 12, 10, − 4Lateral Globus Pallidus8.29Cluster 364026.2, 5.9, − 826, 6, − 8Putamen11.13Cluster 449611.4, 14.4, − 8.314, 16, − 6Caudate (head)8.55Cluster 5160− 3.9, 10.1, − 2.1− 4, 10, − 2Caudate (head)8.05  PatientsCluster 184817.7, 12.3, − 0.418, 8, − 2Putamen7.5118, 16, 0Caudate (body)6.58Cluster 24164.2, 8.2, 3.54, 8, 4Caudate (head)8.28Cluster 3392− 8.2, 12.4, 3.8− 8, 12, 4Caudate (body)8.28  All tasks combinedControlsCluster 130,9922, 4.7, 2.4− 18, 0, 10Putamen38.16− 22, 6, − 6Putamen37.6814, 6, 10Caudate (body)32.8716, 6, − 2GPe26.4928, 6, 0Putamen24.7522, − 2, 12Putamen22.7526, 0, 2Putamen22.7426, − 2, 8Putamen21.0712, 12, − 12Caudate (head)19.98− 8, 10, − 14Caudate (head)15.3930, − 12, − 6Putamen14.38− 30, − 12, − 2Putamen10.07Cluster 214643.8, − 21.5, − 1244, − 22, − 10Red Nucleus19.838, − 18, − 10Red Nucleus17.20− 2, − 24, − 18Red Nucleus14.47  PatientsCluster 1896021, 2, 3.924, 4, 10Putamen27.3424, − 4, 10Putamen17.9928, − 2, − 2Putamen16.2020, − 6, − 2GPi15.8916, 10, − 12Putamen15.5016, 2, 18Caudate (body)14.7614, 14, − 12Caudate (head)14.5526, − 16, − 2GPe13.5414, 12, − 2Caudate (head)12.4516, 0, 26Caudate (body)10.04Cluster 23928− 15, 10.5, − 3.9− 14, 12, − 10Putamen21.13− 12, 10, − 2Caudate (head)20.67− 18, 12, − 12Putamen19.73− 20, 10, 8Putamen12.10− 22, 2, 10Putamen10.36Cluster 373621.8, 27.4, 6.822, 28, 8Caudate (body)15.12

Across emotion studies, there were several significant clusters of activation in control groups, primarily in the caudate. Overlap in activation during executive function tasks was seen primarily in anterior regions of the putamen, while that for language was seen across the caudate and putamen, but also included areas in the globus pallidus *pars externa* (GPe). Motor activation overlap in controls was also localized to the putamen. Perhaps not surprisingly, reward tasks showed overlapping activation in regions of the brainstem due to areas that were described in the original works as "ventral striatum", but there were additional overlaps in the caudate, putamen, and GPe. Finally, analysis of working memory tasks across studies demonstrated significant overlap in the caudate head and putamen, as well as one pallidal region (GPe).

When we contrast individual task domains relative to activity overlap across all other tasks, we begin to see further evidence in support of a functional topography in the basal ganglia of healthy controls, particularly with respect to the specificity of these activation patterns. Detailed coordinates describing these differences within healthy controls are presented in [Table 3](#t0015){ref-type="table"}, and visualized in [Fig. 2](#f0010){ref-type="fig"}. Interestingly, when compared to the combined activation of all other tasks investigated here, we found distinct activation foci across all behavioral domains of interest. With respect to executive function, the largest distinct area of overlap was in the right rostral putamen, though there was also a large cluster of overlap in the caudate head. Notably, these areas of overlap are in the rostral aspects of these structures, areas which are connected to medial prefrontal (MPFC) and orbital frontal cortex (OFC), as mapped by [@bb0120]. Contrasting activation across emotion tasks with all other task domains revealed two significant clusters in the caudate head, and one in the caudate body, analogous to regions connected to the MPFC and OFC ([@bb0120]). The region in the caudate body is located such that it overlaps with areas more likely to be connected with dorsolateral prefrontal cortex (DLPFC).Fig. 2Functional topography of basal ganglia activation. Unique areas of overlap across studies for each task domain, when compared with activation combined across all other tasks, are shown in the sagittal (**A**), coronal (**B**), and axial planes (**C**).Fig. 2Table 3Distinct basal ganglia by individual task domain in control individuals only. For each task, activation patterns across studies for one domain were contrasted with the activation concatenated for every other domain of interest. Thus, this represents distinct activation for a given task.Table 3ClusterCluster size (mm^3^)Weighted center (x,y,z)Local extrema (x,y,z)LocationALE value (× 10^− 3^)Executive functionCluster 1220824.3, 8.9, 6.322, 12, 2Putamen3.7228, − 4, 18Putamen2.3822, 8, 14Caudate (body)2.1724, − 8, 10Putamen1.9628, 2, 20Claustrum1.76Cluster 2664− 7.6, 11, − 13.7− 6, 8, − 10Caudate (head)1.85− 8, 15, − 17Caudate/Gray Matter1.82Cluster 323212.4, 11.1, − 15.312, 10, − 14Caudate/Gray Matter1.89  EmotionCluster 1288− 14, 11.2, 15.2− 14.2, 12.5, 15.4Caudate (body)1.81Cluster 216819.6, 25.4, − 3.418, 26, − 6Caudate (head)2.79Cluster 3645.3, 3.2, − 3.26, 4, − 4Caudate (head)1.71  LanguageCluster 11256− 17.6, 11.9, 3.220, 12, 4Putamen3.29Cluster 2360− 10.9, − 4.7, 18.4− 10, − 4, 20Caudate (body)2.40− 10, − 8, 18Caudate (body)2.36Cluster 372− 2, 12.2, 3.1− 4, 14, 2Caudate (body)1.84  MotorCluster 11532− 20.2, 2.4, − 3.1− 18, − 2, − 4Globus Pallidus *pars externa*3.35− 18, 3, − 5Globus Pallidus *pars externa*3.12Cluster 290422.1, − 4.1, 7.724, − 6, 0Globus Pallidus *pars externa*2.4422, − 4, 8Globus Pallidus *pars externa*2.36Cluster 3280− 29.6, − 11.4, − 1.7− 26, − 10, − 2Globus Pallidus *pars externa*2.26  RewardCluster 1324012.8, 6.7, 3.98, 8, 10Caudate (body)3.5411, 12, 9Caudate (body)3.1914, 6, − 6Globus Pallidus *pars externa*2.77Cluster 221123.6, − 21.4, − 12.64, − 14, − 10Midbrain (Mammilary Body)3.040, − 20, − 9Midbrain (Red Nucleus)3.01− 4, − 20, − 14Midbrain (Red Nucleus)2.998, − 16, − 9Midbrain (Substantia Nigra)2.887.6, − 18, − 14.8Midbrain (Red Nucleus)2.831.2, − 24.5, − 15--2.61Cluster 31416− 9.7, 8.1, 0.4− 9, 6, 1Caudate (Head)3.09Cluster 4152− 25.2, 1.2, − 8.6− 26, 0, − 10Putamen1.72Cluster 55631.4, 2, 232, 2, 2Putamen1.95  Working memoryCluster 11664− 18.1, − 1.2, 11.7− 17.9, − 1.3, 12.5Thalamus3.71Cluster 232027, 5.2, − 8.526, 8, − 8Putamen1.8528, 8, − 12Putamen1.85Cluster 3264− 24.2, 11.3, − 11.1− 22, 12, − 14Putamen1.95− 26, 13, − 11Putamen1.94

Distinct activation overlap associated with language task was localized to the left hemisphere, and relatively rostral. Indeed, the peak activation area in the putamen is quite similar to what we found with respect to executive function (see [Table 3](#t0015){ref-type="table"}). However, there was also overlap in caudal regions of the caudate body, where connectivity is strongest with sensorimotor regions ([@bb0120]). Motor task overlap across studies was distinct in the globus pallidus *pars exerna* (GPe). The largest cluster was localized to the left hemisphere, consistent with the laterality of motor connections, and the predominant focus on right-handed individuals in brain imaging research, though there was also a cluster in the right hemisphere as well. Within the GPe, the activation overlap was localized across much of the structure, though notably, Cluster 3 is in the caudal aspects where connectivity is with motor cortical regions of the brain ([@bb0120]).

Reward tasks showed the largest number of independent clusters of overlap when compared to the other task domains in healthy controls (5 clusters, [Table 3](#t0015){ref-type="table"}). Most notably, was the distinct activation in the midbrain, including the substantia nigra. However, there was also distinct overlap in the caudate head, rostral aspects of the GPe, and the caudate body. Finally, across investigations of working memory, in control subjects we see a distinct region of overlap in the thalamus, which extends into the neighboring regions of the basal ganglia. Specific to the basal ganglia however, there is overlap in the bilateral putamen. These clusters are in more ventral regions of the putamen, that likely to be connected with dorsolateral prefrontal cortical regions ([@bb0120]).

3.2. Task activation overlap in patients with schizophrenia {#s0035}
-----------------------------------------------------------

In patients we did not find any significant overlap in basal ganglia activation in the emotion and executive function task domains. Analysis of language tasks revealed activation overlap across studies in both the putamen and caudate, while that of motor tasks revealed a region of significant overlap in the putamen. Thus, results of the language and motor task analyses were comparable to controls, when we look at general patterns of activation. Across reward tasks there was significant activation overlap in the caudate and putamen in patients with schizophrenia, but unlike in controls we did not see any clusters in the ventral striatum/midbrain. Finally, in patients with schizophrenia, across studies of working memory, there were overlaps in activation in both the caudate (head and body) and putamen. However, it is important to note that there were fewer activation foci in the patients with schizophrenia generally (this is further discussed in the next section, below) which likely contributed to the fewer areas of activation overlap seen in this group. Notably, the patterns of activation across tasks are relatively complicated. However, for our purposes here, our primary interest is in the topography of these overlaps in controls, and the group differences in activation overlap when comparing controls with patients with schizophrenia. As such, we refer readers to [Table 2](#t0010){ref-type="table"} and [Fig. 1](#f0005){ref-type="fig"} for more detailed information about these areas of overlap.

3.3. Group differences in task activation {#s0040}
-----------------------------------------

As noted above, there were several task domains without any significant activation overlaps in the patients with schizophrenia. In looking at the number of foci per investigation ([Table 1](#t0005){ref-type="table"}) there were fewer foci in the patient group, suggestive of overall decreased activation or a lack of recruitment of the basal ganglia relative to healthy controls across the studies surveyed and included here. To investigate this empirically, we computed the percentage of the total number of studies that had activation in the schizophrenia and control groups respectively ([Table 4](#t0020){ref-type="table"}) and used a *t*-test to compare the two groups across task domains. Patients with schizophrenia had activation in 41.21% of the included investigations, while controls had basal ganglia activation foci in 87.27% of investigations, and this was a statistically significant difference (t~(10)~ = − 3.098, p = 0.011).Table 4Percentage of studies showing basal ganglia activation in each group by task domain. The percentages below represent the studies that include both patient and control participants. \*Domains wherein one additional study was included that investigated only patients with schizophrenia. Healthy controls were not included in the study, and thus are not included in the percentages below.Table 4Task domain (total studies)PatientsControlsEmotion (7)\*0%100%Executive function (7)14.28%100%Language (5)80%60%Motor (6)66.67%100%Reward (4)\*50%100%Working memory (11)36.36%63.63%Average across domains41.21%87.27%

To further support this overall general decrease in activation within the patient group, we computed a group comparison collapsing across all tasks. Individual group patterns of overlap collapsing across all task domains, and the results of the group comparison analysis are presented in [Table 5](#t0025){ref-type="table"}. Most importantly, this group comparison when collapsing across all task domains provides further evidence for generalized under-recruitment of the basal ganglia in patients with schizophrenia when compared with controls. Notably, as described above, the ALE analyses control for the number of participants in a given study, and as such the impact of differences in the number of participants across groups is minimized. While there were several clusters of significant overlap in activation across tasks when looking at the conjunction of both groups, there were no areas of greater activation when looking at across study overlap in the patient group relative to controls. There was however significantly greater activation overlap in the control group in a large cluster in the caudate, extending into the thalamus when compared to the patient group ([Fig. 3](#f0015){ref-type="fig"}).Fig. 3ALE results maps when collapsing foci across all task domains presented on coronal slices for the controls (**A**) and the patients with schizophrenia (**B**). Areas where activation was significantly higher in the controls relative to the patients (**C**) and areas where there was significant overlap across the two groups (**D**) are also pictured. There were no areas that showed significantly greater activation across studies in the patients with schizophrenia relative to the controls.Fig. 3Table 5Basal ganglia activation overlap comparisons for each individual task domain, as well as collapsing across all task domains. We present significant group differences and conjunctions for each task domain and collapsed across all tasks. Because there were no significant foci in the emotion and executive function/attention domains, group comparisons were not computed. In addition, there were no significant group differences or overlaps when we computed the analyses of working memory foci, and as such it has not been included in the table. When collapsing across all task domains, there were no clusters where activation was greater in the patients with schizophrenia as compared to the controls. GPe: globus pallidus pars externa; GPi: globus pallidus pars interna.Table 5ClusterCluster size (mm^3^)Weighted center (x, y, z)Local extrema (x, y, z)LocationALE value (× 10^− 3^)LanguageControls \> patientsCluster 1320− 17.3, 11.7, 2− 16, 6, 2Putamen2562.24− 17.4, 12.5, 2.1Putamen2467.66Cluster 264− 11, 10.5, 8.5− 10.4, 10.4, 9.2Caudate (body)2489.29  MotorGroup overlap (conjunction)Cluster 191222.8, − 2.1, 9.422, 0, 10Putamen12.6524, − 4, − 2GPe6.10Cluster 2826, − 6, − 226, − 6, − 2GPe4.96  RewardGroup overlap (conjunction)Cluster 1608− 12.8, 9.5, − 3.7− 12, 8, − 4GPe13.83Cluster 228012.1, 11, 2.812, 12, 4Caudate (body)8.7212, 10, − 2Caudate (head)7.90Cluster 31615, 4, 1614, 4, 16Caudate (body)7.10  All tasks combinedControls \> patientsCluster 11344− 8.6, 2.1, 14.1− 6, 0, 10Thalamus3352.80− 10, 20, 10Caudate (body)3090.23− 6.8, 3.2, 20.4Caudate (body)2807.03− 16, 0, 2GPe2530.19  Group overlap (conjunction)Cluster 1660820.9, 3.4, 2.924, 0, 12Putamen20.1924, − 4, 10Putamen17.9928, − 2, − 2Putamen16.2014, 10, − 12Caudate (head)14.6214, 14, − 12Caudate (head)14.5514, 12, − 2Caudate (head)12.4528, − 14, − 4GPe11.7520, − 2, − 2GPe11.30Cluster 22984− 14.7, 9.7, − 1.5− 12, 10, − 2Caudate (head)20.67− 14, 10, − 8Putamen18.59− 18, 12, − 10Putamen18.43− 10, 12, − 12Caudate (head)12.88− 18, 12, 6Putamen12.05− 20, 8, 8Putamen12.00− 22, 2, 10Putamen10.37

The results of the group comparisons by individual task are also presented in [Table 5](#t0025){ref-type="table"}. Since there were no significant areas of overlap in the patients with schizophrenia for both the emotion and executive function domains, we were unable to calculate any group differences or overlaps between the two groups for these domains. With respect to language, there were no regions of overlap between the two groups; however, controls showed significantly larger regions of activation across investigations in the caudate and putamen during language-related tasks. There were no regions where there was greater activation across tasks in the patient group when compared to controls. In the motor domain, there were no group differences in either direction, though there was significant overlap in the putamen and the GPe. Similarly, with reward, we only found significant areas of overlap in the GPe and caudate. However, though the controls showed significant patterns of activation across studies in the ventral striatum and midbrain, this was not significantly higher in the group comparison, perhaps due to the lower power for this analysis. Finally, there were no differences in working memory, nor were there any regions that were significant in our conjunction analysis.

4. Discussion {#s0045}
=============

Using ALE meta-analysis we investigated basal ganglia activation patterns across task domains in patients with schizophrenia in comparison with healthy controls. First we demonstrated a functional activation topography in healthy controls consistent with the literature investigating parallel loops with the cerebral cortex ([@bb0120], [@bb0115]). Looking across cognitive, motor, and affective task domains, there was a striking general pattern of decreased basal ganglia recruitment in the patient group. Together, these findings provide important new insight into the functional topography of the basal ganglia and basal ganglia function in schizophrenia. We first discuss the patterns seen in healthy controls to provide appropriate context for discussion of the patient findings, particularly in the context of the dopamine hypothesis.

4.1. Activation overlap in healthy individuals and basal ganglia circuits {#s0050}
-------------------------------------------------------------------------

In healthy adults, there are distinct circuits of the basal ganglia connecting these subcortical nuclei to different regions of the prefrontal cortex. Broadly, these circuits are defined by limbic, prefrontal, and motor/occulo-motor connections ([@bb0005], [@bb0010]). In general, the task domains we looked at group roughly into the primary parallel loops of the basal ganglia circuits, though we did not investigate occulomotor tasks. Motor activation in healthy controls is localized in the putamen when looking at motor activation on its own ([@bb0115], [@bb0445]). Generally, this finding is highly consistent with our understanding of the role of the putamen in motor function. Relative to the activation overlap for all other tasks, we found activation overlap clusters specific to motor tasks in the GPe, in regions associated with basal ganglia-motor loops ([@bb0120]). While this specific activation in the GPe is not surprising given the connectivity pattern of this region, this novel finding is of great interest, given that the putamen is often associated with motor function. The role of the basal ganglia in language is less clear, but it has been suggested that the putamen may be involved in initiating phonological representations important for language production and processing ([@bb0055]) and in the sequencing of linguistic information ([@bb0075]). As evidenced by the included foci described in [Table 2](#t0010){ref-type="table"}, it is clear that the basal ganglia are activated across a variety of language processing tasks. The broad pattern of activation seen across language studies may be due to initiation and sequencing with respect to language in ways that are analogous to what occurs during motor processing and sequencing ([@bb0055], [@bb0075]). Activation overlap specific to language however was focused on the putamen and caudate in the left hemisphere, consistent with the lateralization of language processes. The specific putamen region was quite rostral, and consistent with areas connected to the prefrontal cortex ([@bb0120]) while the areas of overlap in the caudate are in regions associated with sensorimotor function. The rostral overlap and resulting prefrontal overlap may be due to the highly cognitive nature of many of the tasks included in this investigation ([Table 1](#t0005){ref-type="table"}), while the areas associated with sensorimotor networks may reflect the motor aspects related to speech and language, though these tasks were non-vocal.

Tapping into the pre-frontal/associative loop are the executive function/attention and working memory domains. Activation overlap across tasks investigating executive function and attention was largely in the putamen, but localized to the anterior regions ([Fig. 1](#f0005){ref-type="fig"}A). When we tested the specificity of the overlap across executive function tasks, they were indeed localized to the rostral putamen, but also the caudate head. This anterior region of the putamen and the caudate head are both associated with the prefrontal cortex, specifically MPFC and OFC ([@bb0120]), the latter of which is heavily implicated in executive function ([@bb2000], [@bb3000]). The implication of the putamen and caudate head in this functional domain is consistent with the connectivity patterns of this region ([@bb0120], [@bb0115]). Working memory overlap was seen in the caudate head and putamen, though activation specific to working memory tasks was localized to the thalamus and putamen. Interestingly, and importantly, the unique regions of working memory activation overlap were in more caudal regions of the putamen then those associated with executive function ([Fig. 2](#f0010){ref-type="fig"}), and these areas are associated with dorsolateral prefrontal cortex, which has been heavily implicated in working memory processes (e.g., [@bb0240], [@bb0465]).

Finally, both emotion processing and reward tasks allow us to investigate the basal ganglia in light of the limbic loop. Consistent with the animal and human literature on reward processing (eg., [@bb0490], [@bb0495], [@bb0500], [@bb0510], [@bb0540]), we saw overlap during reward tasks in the ventral striatum and regions of the midbrain analogous to the substantia nigra. Our investigation of distinct activation during reward processing also revealed midbrain regions that were unique to the domain, in addition to rostral regions in the GPe and caudate head. These more rostral regions of overlap are consistent with the fronto-striatal circuitry, particularly in the OFC thought to underlie reward processing as investigated in non-human primate models ([@bb0495]). Emotion processing tasks were primarily localized to the head of the caudate, though these regions extended into ventral striatal regions, consistent with the limbic loops of the basal ganglia. The clusters in the rostral caudate are analogous to regions connected to the MPFC and OFC ([@bb0120]). Indeed, these frontal regions have been implicated in emotion regulation and the cognitive control of emotion (reviewed in [@bb0145], [@bb0415]).

Together, these findings provide key new insights into the functional topography of the basal ganglia and to our knowledge represent the first meta-analytic investigation of basal ganglia function of its kind. This builds upon our understanding of cortico-striatal loops (eg., [@bb0005], [@bb0010], [@bb0195]) and provides an important point of comparison for investigations of psychopathology where the basal ganglia are implicated. Most critically, with our analysis of the *unique* areas of overlap with each task domain, we were able to produce a map of functional topography in the basal ganglia that is highly consistent with the connectivity patterns of the structure ([@bb0120], [@bb0115]). We suggest that activation across basal ganglia nuclei and different task domains is due to the processing in these regions being conducted on distinct input from different cortical regions, and are subsequently relaying the output of these neural computations back to the cortical targets.

4.2. Activation overlap differences in patients with schizophrenia {#s0055}
------------------------------------------------------------------

Most notably, we demonstrated that there are generally fewer areas of activation overlap in patients with schizophrenia. As noted in our results, when we compare the percentage of studies that had basal ganglia activation foci in the patient group, this was significantly smaller than in the controls. When looking at individual task domains, there are no domains in which there was more activation seen in patients relative to controls, and this is consistent with our results seen when we collapse across all task types. Though there are several large areas of overlap suggesting that the patients are recruiting these nuclei to some degree, patients with schizophrenia are not activating the basal ganglia across task domains and studies to the same extent as healthy controls. Together, this suggests broad basal ganglia dysfunction across studies and samples of patients with schizophrenia, and to our knowledge this is the first large-scale analysis of basal ganglia activation patterns in patients with schizophrenia, making these findings especially novel.

4.3. Implications for our understanding of disease {#s0060}
--------------------------------------------------

In light of the proposed contributions of the basal ganglia to the etiology of schizophrenia, these patterns are especially revealing. Dopaminergic function has been heavily implicated in schizophrenia, as is underscored in the dopamine hypothesis ([@bb0215]). It is also consistent with earlier suggestions that fronto-striatal function is altered in patients with schizophrenia ([@bb0470]). However, it is notable that the typical pattern of dopaminergic progression with the development of schizophrenia suggests increases in striatal dopamine synthesis ([@bb0205], [@bb0210]) while our results here demonstrate an overall decrease in basal ganglia activation across task domains. In patients with Huntington\'s Disease, as well as in those in the pre-clinical stages of disease, there are also patterns of decreased brain activation relative to controls, including activation in the basal ganglia ([@bb0265], [@bb0590], [@bb0615]), though this is a disease characterized by hyperkinetic movements and an excess of dopamine. Thus, our general findings of decreased basal ganglia activity even in the presence of an increase in striatal dopamine are consistent with those seen in Huntington\'s Disease.

Schizophrenia is characterized by heterogeneous symptom profiles featuring both positive and negative symptoms ([@bb0015]), in addition to cognitive dysfunction (eg., [@bb0025], [@bb0140], [@bb0190], [@bb0460]) and motor abnormalities (eg., [@bb0040], [@bb0030], [@bb0065], [@bb0375], [@bb0355], [@bb0380], [@bb0580]). While the dopamine hypothesis and elevated striatal dopamine has been linked to the positive psychotic symptoms of the disease ([@bb0215]) and likely contributes to some of the motor abnormalities seen in schizophrenia ([@bb0580]), this overall pattern may be important for our understanding of negative symptoms and cognitive dysfunction as well. While recent work has linked negative symptoms to cerebellar-mediated behaviors ([@bb0030], [@bb0100]), the basal ganglia may also be an important locus for our understanding of this key symptom domain. Crucially, negative symptoms have been linked to hypofrontality in patients with schizophrenia ([@bb0450], [@bb0595]) and the limbic loop of the basal ganglia is of particular interest. Indeed, in a review of reward processing in schizophrenia, it was suggested that aberrant cortical-striatal interactions with respect to this domain may be especially important for our understanding of the negative symptoms present in the disease ([@bb0530]). Negative symptoms include apathy and a general lack of motivation, which is consistent with the dampened basal ganglia activation found here across studies investigating reward processing and emotion. Indeed, unlike in controls, there were no significant foci of activation in the basal ganglia across emotion tasks. Furthermore, in these investigations of hypofrontality it is notable that regional blood flow in the basal ganglia is one of the regions correlated with negative symptom severity ([@bb0450]), while [@bb0245]) found that functional activation in the ventral striatum during reward processing was correlated with negative symptom severity in patients with schizophrenia. Together, these findings and our evidence for decreased recruitment of the basal ganglia in patients with schizophrenia provide support for the importance of this region, particularly for our understanding of both the positive and negative symptom domains.

With respect to cognition, as we demonstrated here, there is robust activation in the basal ganglia across studies and cognitive task domains. The general lack of activation in patients with schizophrenia, particularly relative to controls in these domains suggest that the basal ganglia may be contributing to the wide array of cognitive deficits experienced by these patients. Most likely, this is mediated by the connectivity with the prefrontal cortex (eg., [@bb0005], [@bb0115], [@bb0120], [@bb0195], [@bb0340]). Thus, the marked differences and general decreases seen in basal ganglia activation in patients with schizophrenia relative to controls suggest that basal ganglia deficits are present in a variety of domains, and may have broader reaching impacts for symptoms and function in this population. Indeed, studies have indicated that basal ganglia activation is related to symptom severity in patients with schizophrenia ([@bb0170], [@bb0515]).

4.4. Limitations {#s0065}
----------------

While our investigation here provides key new insights into basal ganglia function in patients with schizophrenia, there are several limitations to consider. First, this patient population is heterogeneous. Participants across the included studies were often on medication of different types, had comorbidities, and varied with respect to time since diagnosis. Medication in particular has wide ranging effects and may influence motor function, though cognition, emotion and reward processing may all be impacted as well. Importantly, we were unable to incorporate medication status in our analyses. Information reported varied across studies, and currently, the ALE methods included here do not allow for the inclusion of additional variables such as this. Similarly, as previously noted, there is substantial evidence to suggest that the basal ganglia are smaller in patients with schizophrenia. This heterogeneity may also contribute to the activation patterns and group differences found here and we were unable to account for volumetric differences in our analyses. Second, the way in which we determined studies for inclusion was specific to the basal ganglia. We only included studies that showed basal ganglia activation. There are many additional studies that investigate similar task domains, but may not have shown basal ganglia activation in patients or controls. As such, though we have collapsed across numerous investigations, this analysis does not take into account every neuroimaging study of patients with schizophrenia, as is standard with this type of investigation (e.g., [@bb0040]). Thus, our results are only indicative of those investigations that showed basal ganglia activation, and our interpretations should be considered with this in mind. Further, we focused solely on the basal ganglia themselves and did not investigate concomitant cortical activation. Future work would benefit from taking this into account.

We surveyed a significant proportion of the literature, and searched broadly across all studies in Pubmed using neuroimaging in patients with schizophrenia, but we ultimately were only able to focus on studies that showed activation in the basal ganglia in one group. While an investigation of the consistency of basal ganglia activation within a given domain would be quite interesting, it is beyond the scope of this investigation. Relatedly, our functional topography in healthy controls is somewhat limited given that this is a smaller sampling of studies, limited to cases where healthy individuals were serving as controls for patients with schizophrenia. Thus, our healthy control topography is that which is present in this limited sample. In our *t*-test comparison of control and patient groups investigating the relative proportion of studies showing the basal ganglia, it is important to note that this does not account for relative sample size (unlike our ALE analysis). The general lack of activation in some domains and studies contributing to these group differences may be driven by sample size differences and statistical power. With that said, this is somewhat unlikely, given that across all 40 studies included in our analyses here, there were more patients than controls (n = 707 patients; n = 583 controls). Finally, we must consider the contributions of task demands. While we did not assess or quantify behavioral differences in the studies we included as we were focused solely on activation differences, it is notable that these investigations were designed for clinical populations. With that in mind, task demands were likely not optimal for the control group, to ensure that the patients are able to effectively complete the task of interest. This may as a result be impacting our findings. If anything, we suggest that if the tasks were better optimized for healthy controls, the differences with patients may be even more striking.

5. Conclusions {#s0070}
==============

Using state-of-the-art neuroimaging meta-analysis methods we investigated basal ganglia activation across task domains (motor, cognitive, and affective) in studies of patients with schizophrenia. Looking at the healthy control data only, we provide a functional topography of basal ganglia activation consistent with the parallel loops seen in the cortex. Crucially, when looking at patients with schizophrenia, we found an overall decrease in basal ganglia activation across all domains, and in specific task domains as well. Indeed, in the emotion and executive function/attention domains there were no significant regions of activation overlap across studies, while this was present for healthy controls. Given the parallel motor/occulo-motor, frontal, and limbic loops between the basal ganglia and cortex, we suggest that the basal ganglia deficits shown here may contribute to both negative symptoms and cognitive dysfunction in patients with schizophrenia, in addition to the positive symptoms and motor dysfunction associated with the dopamine hypothesis.
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